ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

MAHRUKH HUSSAIN M.D.

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

18,580Medicare Part D Prescriptions Filled, Including Refills

Rank: 158 out of 3593

$956K Total Retail Price of All Prescriptions

Rank: 150 out of 3593

874 Patients Receiving at Least One Drug in Part D
51%Patients 65 Years and Older
93% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 874 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

27% of this provider’s 874 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

3% of this provider’s 10,707 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
HYDROCODONE-ACETAMINOPHEN 1,093 455 S3 1 7
LISINOPRIL 958 568 2 2
HYDROCHLOROTHIAZIDE 952 539 3 10
AMLODIPINE BESYLATE 925 601 4 3
CRESTOR 555 408 5 21
METOPROLOL TARTRATE 415 326 6 8
NEXIUM 410 241 7 36
FUROSEMIDE 400 279 8 9
OMEPRAZOLE 352 145 9 5
SIMVASTATIN 351 170 10 1
PRAVASTATIN SODIUM 344 184 11 13
LEVOTHYROXINE SODIUM 317 201 12 4
RAMIPRIL 315 225 13 92
LOSARTAN POTASSIUM 311 193 14 14
METFORMIN HCL 309 205 15 6
KLOR-CON 10 284 212 16 114
SINGULAIR 284 188 16 77
RANITIDINE HCL 266 188 18 27
FLUTICASONE PROPIONATE 257 150 19 32
GABAPENTIN 255 109 20 16
IBUPROFEN 245 130 21 43
ALENDRONATE SODIUM 242 197 22 22
TRAMADOL HCL 239 133 23 17
TRAZODONE HCL 209 100 24 53
CITALOPRAM HBR 208 74 25 25
POTASSIUM CHLORIDE 196 124 26 24
METOPROLOL SUCCINATE 190 113 27 19
CYCLOBENZAPRINE HCL 188 46 R 28 72
ADVAIR DISKUS 185 108 29 47
XOPENEX HFA 170 104 10 30 343
MELOXICAM 157 84 31 29
SERTRALINE HCL 154 70 32 28
GLYBURIDE 154 128 R 32 55
CARVEDILOL 144 92 34 23
TRIAMCINOLONE ACETONIDE 144 76 34 119
METFORMIN HCL ER 139 88 36 67
WARFARIN SODIUM 138 62 37 18
FELODIPINE ER 136 111 38 229
PLAVIX 127 104 39 42
TERAZOSIN HCL 125 89 40 115
DETROL LA 115 81 41 262
CLOPIDOGREL 111 87 42 30
TOPROL XL 109 89 43 390
ATENOLOL 109 63 43 11
MIRTAZAPINE 104 38 45 64
LANTUS 100 55 46 57
MONTELUKAST SODIUM 100 56 46 151
AMITRIPTYLINE HCL 97 61 R 48 90
HYDRALAZINE HCL 95 71 49 107
SPIRIVA 95 54 49 87
FLUOXETINE HCL 94 45 51 60
PROAIR HFA 94 35 51 54
ATORVASTATIN CALCIUM 93 55 53 15
METHOCARBAMOL 90 27 R 54 185
CELEBREX 88 54 55 100
PAROXETINE HCL 88 37 55 62
ISOSORBIDE MONONITRATE ER 83 69 57 61
CLONIDINE HCL 81 45 58 41
TIZANIDINE HCL 78 37 59 120
OXYCODONE HCL 77 18 S2 60 59
INSULIN SYRINGE 77 52 60 91
PREMARIN 76 65 R 62 204
ACTOS 75 51 63 133
LIPITOR 74 56 64 136
MORPHINE SULFATE ER 71 13 S2 65 108
OXYCODONE-ACETAMINOPHEN 68 29 S2 66 93
OXYCONTIN 68 15 S2 66 166
GLIPIZIDE ER 67 45 68 101
BUPROPION HCL SR 65 11 69 207
LYRICA 65 13 69 105
AMOXICILLIN 59 26 71 128
ZETIA 57 36 72 110
OXYCODONE HCL-ACETAMINOPHEN 56 11 S2 73 82
OXYBUTYNIN CHLORIDE 53 48 74 104
NAPROXEN 52 21 75 68
CLOTRIMAZOLE 51 21 76 319
VENLAFAXINE HCL ER 50 0 77 178
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 22, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.